AC Immune has received FDA Fast Track designation and IND [...]

BioVie has reported topline results from a Phase 2 trial [...]

ABLi Therapeutics has reported coordinated changes across 11 biomarkers linked [...]

CONNECTA Therapeutics will present preclinical data supporting its Phase 2a [...]

TRIMTECH Therapeutics has secured an additional $14 million in seed [...]

Emalex Biosciences has secured a US patent for an orally [...]

AC Immune has amended its collaboration agreement with Eli Lilly [...]

AC Immune has initiated a Phase 1 trial of its [...]

Newron Pharmaceuticals has secured up to EUR 38 million in [...]

Endometriosis is typically treated as a single condition, yet patients [...]